Navigation Links
Neurologix Announces Second Quarter 2011 Financial Results
Date:8/11/2011

FORT LEE, N.J., Aug. 11, 2011 /PRNewswire/ -- Neurologix, Inc. (OTCBB: NRGX), a biotechnology company engaged in the development of innovative gene therapies for disorders of the brain and central nervous system, today announced its financial results for the three and six months ended June 30, 2011.

For the three months ended June 30, 2011, Neurologix reported a net loss of approximately $3.0 million, as compared with a net loss of approximately $4.5 million for the three months ended June 30, 2010. Net loss for the three months ended June 30, 2011 includes other income of approximately $1.3 million recognized for the change in estimated fair value of the Company's derivative financial instruments relating to certain warrants issued in connection with promissory notes issued by the Company in December 2010 (the "Notes"), the Company's Series D Convertible Preferred Stock (the "Series D Stock") and the Company's Series C Convertible Preferred Stock (the "Series C Stock"). The second quarter 2011 net loss also includes interest expense related to the Notes of approximately $1.4 million. Net loss for the three months ended June 30, 2010 included charges of approximately $2.2 million recognized for the change in estimated fair value of the Company's derivative financial instruments relating to warrants issued in connection with the Series D Stock and the Series C Stock.

The Company reported a net loss applicable to common stock for the three months ended June 30, 2011 of approximately $3.8 million, or $0.14 per basic and diluted share, as compared with a net loss applicable to common stock for the three months ended June 30, 2010 of approximately $5.3 million, or $0.19 per basic and diluted share. Net loss applicable to common stock includes charges related to preferred stock dividends in connection with the Series D Stock and the Series C Stock of approximately $0.8 million, or $0.03 per basic and diluted share, for each of the three months ende
'/>"/>

SOURCE Neurologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Neurologix Presents One-Year Follow-Up Data From Phase 2 Study of NLX-P101 in Parkinsons Disease at International Neuromodulation Society 10th World Congress
2. Bion Announces New U.S. Patent for Phosphorus Removal
3. ViaCyte Announces Executive Management Changes
4. NeoStem Announces the Receipt of Over $1,700,000 in DOD Funding for its VSEL™ Technology Being Developed to Treat Osteoporosis
5. Dendreon Announces Webcast Presentation at Canaccord Genuity Growth Conference
6. Osteologix Announces Completion of Corporate Consolidation
7. Interleukin Genetics, Inc. Announces Conference Call to Discuss Second Quarter 2011 Results
8. Palatin Announces Commencement of a Phase 1 Trial for Obesity Compound in Collaboration with AstraZeneca
9. Rigel Announces Second Quarter 2011 Financial Results
10. WAVi Co. Announces Collaborative Agreement with SomaLogic, Inc.
11. Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Bioscience, Inc. (NASDAQ: ROKA ), a molecular diagnostics ... of foodborne pathogens, today announced that Paul G. Thomas ... Annual Healthcare Conference on December 2, 2014 at 4:30pm ET. ... in New York, NY . ... operations, strategies and prospects may be discussed. To listen to ...
(Date:11/24/2014)...   First published articles now ... Elsevier , a world-leading provider of scientific, technical and medical ... of the latest title in the Current Opinion journal ... . Current Opinion in ... to keep up-to-date with the expanding volume of information published ...
(Date:11/24/2014)... November 24, 2014 The new ... from METTLER TOLEDO demonstrates how to reduce the ... analytics and sample panel design can be complicated, ... and protect against corrosion and deposition. Dedicated single ... significant amount of panel space. Additionally, installing and ...
(Date:11/22/2014)... 21, 2014 During his lifetime Richard ... need to surround himself with great people and take ... his friends often marveled at his extraordinarily courageous attitude ... life and -- even with his death impending—that’s how ... disease that would ultimately take his life. , Carrying ...
Breaking Biology Technology:Roka Bioscience to Present at the Piper Jaffray Healthcare Conference 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 3New Video Shows How to Simplify Cycle Chemistry Sample Panels to Save Time and Costs 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 3
... ... Spectrum Chemicals & Laboratory Products (Spectrum) announced the distribution launch ... productivity and lessen injuries due to repetitive hand crimping. ... engineered to improve throughput in laboratories performing chromatography, analytical testing, ...
... , , FRAZER, Pa., Aug. ... that it has completed its previously announced acquisition of all of ... As a result of the acquisition, Arana is now a ... and CEO, Frank Baldino Jr., Ph.D., said, "We are excited about ...
... BEIJING, Aug. 10 /PRNewswire-Asia-FirstCall/ -- Yongye International, Inc.,(OTC ... developer and,distributor of Shengmingsu branded plant and animal nutrient ... that the Company expanded,its research and development center in ... greenhouses and an open testing field. , ...
Cached Biology Technology:Spectrum Announces New Distribution of AC-Powered Tool for Crimping and Decapping of Laboratory Vials - The CRIMPenstein™ 2Cephalon Completes Acquisition of Arana Therapeutics 2Cephalon Completes Acquisition of Arana Therapeutics 3Yongye International Announces Expansion of Research and Development Center 2Yongye International Announces Expansion of Research and Development Center 3
(Date:11/21/2014)... NEW YORK , Nov. 19, 2014  Earlier ... Board at New York College, and one of the ... for biosensor signals that are transmitted from Smartphones to ... there were Smartphones and has one of the earliest ... are discussing its usage in the military, child care, ...
(Date:11/18/2014)... , Nov. 18, 2014  The Secure ... Industry Association today jointly announce the formation of ... release of its Identity and Biometric Entry ... The Framework received official support from BORDERPOL, the ... to improve and provide expertise regarding border security, ...
(Date:11/15/2014)... YORK , Nov. 13, 2014  While we may ... technology Doctor McCoy used in "Star Trek" to gain instant ... tools designed to work with smartphones and tablets for monitoring ... of the healthcare world. This may seem a tad Orwellian ... ready to adopt some of these technological opportunities into their ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4
... 3 issue of Nature, Johns Hopkins researchers report that ... come together to turn the liver into a sugar-producing ... of sugar is a damaging problem in people with ... future drugs to fight the disease, the researchers say. ...
... Mayo Clinic researchers and conducted by the North Central Cancer ... for an incurable form of recurrent brain cancer slowed tumor ... who tried it. The same research team also developed a ... to this treatment. , Mayo researchers will present these findings ...
... by camouflage in the same way that humans are deceived, ... idea that bold contrasting colours help to break-up the body's ... as the First World War. And in biology this idea ... insects such as moths conceal themselves from predators, shaping the ...
Cached Biology News:Computational verification of protein-protein interactions by orthologous co-expression 2Computational verification of protein-protein interactions by orthologous co-expression 3'Smart drug' targets deadly brain cancer 2'Smart drug' targets deadly brain cancer 3
... Immunogen: Synthetic peptide derived from the C ... protein This peptide sequence is downstream ... Zymed polyclonal Connexin 36 antibody Cat. No. ... 36. Reactivity: Mouse (positive control: mouse ...
...
...
...
Biology Products: